iifl-logo

Akums Drugs & Pharmaceuticals Ltd Balance Sheet

561
(-1.24%)
May 22, 2025|02:49:58 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

28.61

28.61

14.31

1.3

Preference Capital

0

0

0

0

Reserves

115.27

282.89

171.23

565.75

Net Worth

143.88

311.5

185.54

567.05

Minority Interest

Debt

226.29

145.59

140.16

41.13

Deferred Tax Liability Net

10.31

0

20.59

31.45

Total Liabilities

380.48

457.09

346.29

639.63

Fixed Assets

326

288.65

253.71

245.67

Intangible Assets

Investments

138.92

139.16

141.39

149.46

Deferred Tax Asset Net

0

3.13

7.79

65.21

Networking Capital

-157.76

17.3

-82.32

178.29

Inventories

161.7

197.12

179.31

95.91

Inventory Days

Sundry Debtors

233.79

256.13

303.93

211.66

Debtor Days

Other Current Assets

1,161.7

1,001.17

909.88

560.9

Sundry Creditors

-164.91

-177.97

-253.57

-90.3

Creditor Days

Other Current Liabilities

-1,550.04

-1,259.15

-1,221.88

-599.88

Cash

73.31

8.85

25.74

1

Total Assets

380.47

457.09

346.3

639.63

Akums Drugs & Pharmaceuticals Ltd : related Articles

Akums Drugs & Pharm a shares close at a 17% premium
6 Aug 2024|03:43 PM

The organisation is the largest CDMO serving the Indian pharmaceutical industry, with a proven track record and a broad clientele.

Read More
Akums Drugs Lists With 6% Premium
6 Aug 2024|09:56 AM

The IPO comprised a fresh issue of shares worth ₹680 crore and an offer-for-sale (OFS) of 1.73 crore shares, aggregating ₹1,177 crore.

Read More
Akums Drugs & Pharma IPO subscribed 43 times so far
1 Aug 2024|03:26 PM

The IPO consists of a fresh issue of ₹680 crore and an offer for sale (OFS) of up to 1.73 crore shares at a face value of ₹2 each.

Read More
Akums Drugs IPO Subscribed 3.20 times so far Day 2
31 Jul 2024|03:48 PM

On Monday, the business said that it had received ₹829 crore from anchor investors ahead of the public share sale subscription period.

Read More
Akums Drugs and Pharmaceuticals IPO subscribed 97%
30 Jul 2024|03:09 PM

The IPO includes a new issue of 1 Crore shares worth ₹680.00 Crore and an offer for sale of 1.73 Crore shares worth ₹1,176.74 Crore.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.